PETVIVO HOLDINGS, INC. TO PRESENT AT LD MICRO MAIN EVENT XV
October 18 2022 - 8:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an
emerging biomedical device company focused on the commercialization
of innovative medical devices and other therapeutics for companion
animals, is pleased to announce today that it will be presenting at
the 15th annual Main Event on Wednesday, October 26th at 08:00 AM
to 8:25 AM PT at the Luxe Sunset Boulevard Hotel. John Lai, Chief
Executive Officer, of PetVivo, will be giving the presentation.
"15 years ago, we set out to create an event
that could benefit our entire industry. It wasn't fast or easy, but
we were honorable in our dealings, and worked our tails off to
ensure a wonderful time for everyone involved. Today, our community
could not be larger, stronger, and more united, as we go through
these difficult and turbulent times together. The Main Event is
about learning, connecting, and enjoying each other, and it is a
hell of a lot more fun than sitting next to your computer." stated
Chris Lahiji, Founder of LD Micro.
“We are looking forward to networking with
leaders in the industry and develop relationships that will help
build awareness of our company as well as introduce to the public
the benefits of our initial veterinary medical device for the
management of osteoarthritis, SPRYNG,” said John Lai, Chief
Executive Officer of PetVivo Holdings, Inc.
Event: LD Micro Main Event XV
Conference Dates: October 25-27, 2022
Presentation Date: ______October 26th,
2022__________
Presentation Time: _____8AM- 8:25 AM
PT___________
Register to watch the virtual presentation at
https://me22.sequireevents.com/.
Summary of LD Micro Main Event
XV
The 2022 LD Micro Main Event XV will be held at
the Luxe Sunset Boulevard Hotel in Los Angeles from October 25th to
the 27th.
The event will run from 7:30 AM PT - 5:30 PM PT
on the 25th and 26th, with a half day on Thursday the 27th.
This three-day, investor conference is expected
to feature around 200+ companies, presenting in half-hour
increments, as well as private meetings.
For more info, please contact Mr. Dean "The
Dream" Summers. Dean@ldmicro.com
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG™
with OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/
About LD Micro
LD Micro aims to be the most crucial resource in
the micro-cap world. Whether it is the index, comprehensive data,
or hosting the most significant events on an annual basis, LD's
sole mission is to serve as an invaluable asset for all those
interested in finding the next generation of great companies.
http://www.ldmicro.com
CONTACT:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024